...
首页> 外文期刊>BioMed research international >Low-Dose-Area-Constrained Helical TomoTherapy-Based Whole Breast Radiotherapy and Dosimetric Comparison with Tangential Field-in-Field IMRT
【24h】

Low-Dose-Area-Constrained Helical TomoTherapy-Based Whole Breast Radiotherapy and Dosimetric Comparison with Tangential Field-in-Field IMRT

机译:低剂量区域约束的基于螺旋层析成像的全乳腺放射治疗以及与切向场内IMRT的剂量学比较

获取原文
获取原文并翻译 | 示例

摘要

Background and Purpose. To present a novel helical TomoTherapy-based method for whole breast radiotherapy that has better dosimetry and also has acceptable low-dose regions for lungs, heart, and contralateral breast compared with tangential field-in-field IMRT (FIF-IMRT). Material and Methods. Ten patients with left-side breast cancer were planned with low-dose-area-constrained helical TomoTherapy (LDC-HT) and FIF-IMRT. Dosimetry was compared for all techniques. Results. Coverage of the whole breast was adequate with both techniques. Homogeneity index (HI) and conformity index (CI) were better with LDC-HT. LDC-HT showed dosimetry advantages over FIF-IMRT for ipsilateral lung and heart in not only high-dose levels but also in low-dose levels such as V_(10Gy) and V_(5 Gy). For contralateral lung, both techniques can provide good protection, although the mean dose of LDC-HT is higher than that of FIF-IMRT. Conclusions. With LDC-HT, we obtained adequate target coverage, better HI and CI of target volume, better sparing of organs at risk, and acceptably low-dose areas compared with FIF-IMRT. LDC-HT could be a feasible method in whole breast radiotherapy. Clinical benefits of LDC-HT need further investigation.
机译:背景和目的。提出一种基于螺旋螺旋层析成像的全乳放射治疗方法,与切线场IMRT(FIF-IMRT)相比,该方法具有更好的剂量测定方法,并且对于肺部,心脏和对侧乳房具有可接受的低剂量区域。材料与方法。计划对十名左侧乳腺癌患者进行低剂量区域约束的螺旋TomoTherapy(LDC-HT)和FIF-IMRT。比较了所有技术的剂量测定法。结果。两种技术都足以覆盖整个乳房。 LDC-HT的同质性指数(HI)和合格指数(CI)更好。对于同侧肺和心脏,LDC-HT在FIF-IMRT方面显示出剂量学优势,不仅在高剂量水平,而且在低剂量水平(例如V_(10Gy)和V_(5 Gy))上也是如此。对于L对侧肺,尽管LDC-HT的平均剂量高于FIF-IMRT的平均剂量,但这两种技术都可以提供良好的保护。结论与FIF-IMRT相比,通过LDC-HT,我们获得了足够的靶标覆盖范围,更好的靶标体积HI和CI,更好地保留了有风险的器官以及可接受的低剂量区域。 LDC-HT在全乳放射治疗中可能是一种可行的方法。 LDC-HT的临床益处需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号